Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

What We Have Funded

CLL Society’s Research Program funds the most promising research that is being conducted by bold scientists at leading academic institutions. These investigators represent the nation’s leading experts who are working diligently to advance the field. Since launching the Research Program in 2022, CLL Society has already dedicated a total of $1,500,000 towards funding some of the nation’s top CLL / SLL researchers!

CLL Society’s Research Program award recipients are announced annually in July. Each awardee receives a varied amount of funding towards their research proposal, depending upon the type of grant they applied for and the funding available the year that the award was offered, to advance their important research in CLL / SLL. Recipients of CLL Society’s Research Program Awards are chosen through a rigorous selection process with the guidance and oversight of formal Research Review Committees comprised of volunteer members from our Medical Advisory Board and Expert Medical Council.

2024

Jennifer Brown - CLL Society

Venetoclax and Obinutuzumab in Combination with Roginolisib in CLL / SLL Patients After BTK Inhibitor Failure

Clinical Scholar Award
Jennifer Brown, MD, PhD
Dana-Farber Cancer Institute
Boston, Massachusetts

Delineating the Role of Mitochondrial Dysregulation in Richter’s Transformation

Young Investigator Award
Prajish Iyer, PhD
City of Hope
Duarte, California

Christopher Jensen - CLL Society

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

Integrative Medicine Award
Christopher Jensen, MD, MSCR
University of North Carolina-Chapel Hill
Chapel Hill, North Carolina

Understanding and Targeting Hematopoiesis in CLL and Probiotics

Integrative Medicine Award
John Byrd, MD
University of Cincinnati
Cincinnati, Ohio

2023

Andres Chang - CLL Society

The Adaptive Immune Response in CLL

Andres Chang, MD, PhD
Emory University School of Medicine
Winship Cancer Institute
Atlanta, Georgia

2022

BH3 Profiling to Identify Novel Vulnerabilities in Richter’s Syndrome

Christine Ryan, MD
Dana Farber Cancer Institute
Boston, Massachusetts

Nathalie Javidi-Sharifi, MD, PhD
Dana Farber Cancer Institute
Boston, Massachusetts